Mycophenolate Add-on Therapy Is Effective in Severe IgA Nephropathy
Kidney360 · 18.11.2026
DOI: 10.34067/kid.0000001443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 18.11.2026. Verfasst von Efrain Tatis und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
IgA Nephropathy (IgAN) is the most common primary glomerulonephritis. There is limited evidence on the use of mycophenolate mofetil (MMF) in IgAN in non-Asian populations. This study evaluates the efficacy of MMF in IgAN.
Methods
Retrospective cohort study of patients with biopsy-confirmed IgAN between 2013 and 2024, with at least 6 months of follow-up. Patients were classified into three groups based on the treatment received in the first 6 months after diagnosis: (1) Supportive care, (2) Corticosteroids, (3) MMF add-on. Data were collected at baseline, 3, 6, 12, and 24 months. Changes in estimated glomerular filtration rate (eGFR), urinary protein-to-creatinine ratio (UPCR) and hematuria were assessed. The composite outcome included eGFR
Zitieren
APA
Tatis, E., Nuñez-Delgado, S., Yandian, F., Román, J. L., López, M., Bermejo, S., Agraz, I., Ramos, N., Gabaldón, M. A., Sans, L., Alvarez, T., Barajas, E. S., Bestard, O., & Soler, M. J. (2026). Mycophenolate Add-on Therapy Is Effective in Severe IgA Nephropathy. Kidney360. https://doi.org/10.34067/kid.0000001443
Vancouver
Tatis E, Nuñez-Delgado S, Yandian F, Román JL, López M, Bermejo S, et al. Mycophenolate Add-on Therapy Is Effective in Severe IgA Nephropathy. Kidney360. 2026. doi:10.34067/kid.0000001443
BibTeX
@article{Tatis2026,
author = {Tatis, Efrain and Nuñez-Delgado, Sara and Yandian, Federico and Román, Juan León and López, Marina and Bermejo, Sheila and Agraz, Irene and Ramos, Natalia and Gabaldón, María Alejandra and Sans, Laia and Alvarez, Tiffany and Barajas, Ehimy Suárez and Bestard, Oriol and Soler, María José},
title = {Mycophenolate Add-on Therapy Is Effective in Severe IgA Nephropathy},
journal = {Kidney360},
year = {2026},
doi = {10.34067/kid.0000001443}
}
EUVIMED